What are the risks of investing in AKTS?
A
What are the risks of investing in AKTS?
🦉
Aktis Oncology, Inc. (AKTS)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOMatthew Roden
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the...
Key Executives
| Name | Title |
|---|---|
| Akos Czibere | Chief Medical Officer |
| Carlos Rodriguez | Executive Director of Corporate Development |
| Dasa Lipovsek | VP & Head of Lead Discovery |
| Karen McCarthy | VP & Head of Finance |
| Kyle D. Kuvalanka | Chief Financial Officer |
| Matthew Roden | President, CEO & Director |
Risk Assessment
Weather Score0/100
RegimeN/A